Data / Drug companies / Antacid
Antacid: 10 companies and 20 products in the FDA NDC directory
Antacid is listed in the FDA National Drug Code Directory by 10 companies, with 20 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, chewable; tablet, and the newest product started marketing on May 5, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 20
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- CVS Tropical Fruit, QC Regular Strength, CVS Health Extra Strength Sugar Free, Extra Strength Tropical Fruit, Calcium Carbonate
- openFDA record search
- api.fda.gov
Companies that list antacid
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Walgreen Company | 7 | tablet, chewable | Over the counter monograph drugs | December 19, 2017 |
| CVS Pharmacy | 2 | tablet, chewable | Over the counter monograph drugs | October 19, 2020 |
| Target Corporation | 2 | tablet, chewable | Over the counter monograph drugs | November 11, 2019 |
| United Natural Foods, Inc. DBA Unfi | 2 | tablet, chewable | Over the counter monograph drugs | September 28, 2015 |
| Wal-Mart Stores Inc | 2 | tablet, chewable | Over the counter monograph drugs | August 30, 2017 |
| Allegiant Health | 1 | tablet, chewable | Over the counter monograph drugs | March 22, 2022 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | tablet, chewable | Over the counter monograph drugs | August 5, 2021 |
| Cardinal Health 110, LLC. DBA Leader | 1 | tablet, chewable | Over the counter monograph drugs | February 4, 2019 |
| Chain Drug Marketing Association | 1 | tablet, chewable | Over the counter monograph drugs | July 15, 2022 |
| Xiamen Kang Zhongyuan Biotechnology Co., Ltd. | 1 | tablet | Over the counter monograph drugs | May 5, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 19 | 95% |
| Tablet | 1 | 5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 20 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Blood Coagulation Factor | 7 |
| Phosphate Binder | 7 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.